with Dr. María Fernández-Hevia
There is no doubt that the total mesorectal excision (TME) is the best surgical treatment for rectal cancer. However it may be a challenging procedure with complications between 30 - 68%.
That is why among other reasons radical surgery should be performed in patients with a favorable balance between risk and benefits. There is a group of patients with early rectal cancer (cT1 sm2/sm2 cN0) that may be treated with local resection, achieving curative surgical treatment with less complications.
In this lecture María Fernandez-Hévia from the gastrointestinal surgery department at Hospital Clinic of Barcelona will explain the modern surgical treatment tailored to patients and tumor characteristics.
Share it with your network and help spread clinical knowledge.
